
Fuse Science (DROP) Rallies Despite Market and Its Symbol
Fuse Science (OTC: DROP) continued its recent climb, gaining just under four cents or 12% during a time when equity markets generally swooned throughout the

Fuse Science (OTC: DROP) continued its recent climb, gaining just under four cents or 12% during a time when equity markets generally swooned throughout the

Cannabis Sciences (OTCBB :CBIS) closed higher on Thursday afternoon by a little more than a penny from the previous night’s close. The stock ended the

Omni Ventures (OTC: OMVE) declined over 6% today in a rough trading session for stock markets around the world. The stock closed at a price

The number of shares traded today on ChromaDex (OTCBB: CDXC) far outpaced the average daily volume seen over the last three months. The stock settled

Sirius XM Radio (NASDAQ: SIRI) stock declined for the third consecutive day on less than its average daily volume for the last three months. The

In what could only be described as a fitting end to a week after the Facebook (NASDAQ: FB) IPO debacle, shares of Delcath Systems (NASDAQ:

Shares of Complete Genomics (NASDAQ: GNOM) rocketed Thursday on heavy volume. The move today appeared to be in sympathy with Rosetta Genomics (NASDAQ: ROSG), an

Fuse Science (OTC: DROP) continued its recent climb, gaining just under four cents or 12% during a time when equity markets generally swooned throughout the

Cannabis Sciences (OTCBB :CBIS) closed higher on Thursday afternoon by a little more than a penny from the previous night’s close. The stock ended the

Omni Ventures (OTC: OMVE) declined over 6% today in a rough trading session for stock markets around the world. The stock closed at a price

The number of shares traded today on ChromaDex (OTCBB: CDXC) far outpaced the average daily volume seen over the last three months. The stock settled

Sirius XM Radio (NASDAQ: SIRI) stock declined for the third consecutive day on less than its average daily volume for the last three months. The

In what could only be described as a fitting end to a week after the Facebook (NASDAQ: FB) IPO debacle, shares of Delcath Systems (NASDAQ:

Shares of Complete Genomics (NASDAQ: GNOM) rocketed Thursday on heavy volume. The move today appeared to be in sympathy with Rosetta Genomics (NASDAQ: ROSG), an